Deconstructing Racial Differences in Receipt of Secondary Stroke Prevention Agents in Nursing Homes

ISSN： 1540-5303

Source： Journal of Aging & Pharmacotherapy, Vol.13, Iss.2, 2007-02, pp. : 53-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Antiplatelet Agents Used in the Secondary Prevention of Stroke

By Lenz T.L. Wilson A.F.

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 909-920

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke

By MacWalter R.S. Shirley C.P.

Drug Safety, Vol. 25, Iss. 13, 2002-01 ,pp. : 943-963

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for the Secondary Prevention of Stroke

By Toyoda Kazunori

Drugs, Vol. 69, Iss. 6, 2009-01 ,pp. : 633-647

Adis International

Access to resources Recommend Favorite

Clopidogrel for the secondary prevention of stroke

By Diener Hans-Christoph Ringleb Peter A Savi Pierre

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 755-764

Informa Healthcare

Access to resources Recommend Favorite

Secondary Prevention of Ischemic Stroke

Current Drug Targets, Vol. 5, Iss. 5, 2004-07 ,pp. : 457-472

Bentham Science Publishers

Access to resources Recommend Favorite